# A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment

> **NCT05176496** · — · COMPLETED · sponsor: **Bayer** · enrollment: 99999 (actual)

## Conditions studied

- Heavy Menstrual Bleeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05176496
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-07-15
- **Target enrollment:** 99999 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05176496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05176496, "A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05176496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*